Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: a pilot study by Furusato, E et al.
Inflammatory cytokine and chemokine expression in
sympathetic ophthalmia: a pilot study
Emiko Furusato1,2, DeFen Shen1, Xiaoguang Cao1, Bungo Furusato4, Robert B.
Nussenblatt3, Elisabeth J. Rushing2, and Chi-Chao Chan1
1Immunopathology Section, National Eye Institute, National Institutes of Health, Bethesda
2Clinical Immunology Section, Laboratory of Immunology, National Eye Institute, National
Institutes of Health, Bethesda
3Neuropathology and Ophthalmic Pathology, Armed Forces Institute of Pathology, Washington,
DC, USA
4Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, DC, USA
Summary
Sympathetic ophthalmia is a bilateral uveitis that develops after penetrating injury to one eye. This
study aimed to identify the inflammatory cellular sub-phenotypes and expression of pertinent
inflammatory cytokines/chemokines in sympathetic ophthalmia (SO). Dalen-Fuchs nodules
(DFN), granulomas, and non-granulomatous foci of inflammation were microdissected from 15
cases. RNA was extracted, and quantitative PCR was performed to measure IL-17, IL-18, IL-23,
IFN-γ, CCL19, CXCL11, CCL17, and CCL22 transcripts. Immunohistochemical methods were
used to characterize CD3, CD4, CD8, CD20, CD68, and CD163 expression. Non-granulomatous
lymphocytes were predominantly CD3-positive and expressed more IFN-γ than cells within
granulomas, consistent with Th1 cells. In contrast, granulomas and DFN contained mainly
CD68+, CD163+/− and expressed more IL-17, IL-18, IL-23, CCL19, and CXCL11 than non-
granulomatous cells. Our data indicate for the first time that M1 macrophages are the predominant
inflammatory cells within granulomas and DFN of SO. We further observed high levels of IL-17
within granulomas and the presence of Th1 and M1 cells.
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Introduction
Sympathetic ophthalmia (SO) is a bilateral granulomatous uveitis that develops following
surgery or penetrating trauma to one eye (Sen and Nussenblatt, 2009). Antiretinal
autoantibodies have been detected in SO serum (Chan et al., 1985c) and immunologenetical
studies show evidence of specific HLA haplotypes (e.g., HLA-DR4, DRw53 and DQw3)
and cytokine single nucleotide polymorphisms (SNP) (Davis et al., 1990; Atan et al., 2005).
The cause of SO appears to be a delayed hypersensitivity reaction to antigens localized on
photoreceptors, retinal pigment epithelium (RPE), or uveal melanocytes exposed by the
traumatic event (Jakobiec et al., 1983; Castiblanco and Adelman, 2009). A leading
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hypothesis is that perforating injury permits drainage of uveitogenic antigen from the eye
and small amounts of adjuvant-like molecules to enter the eye and exacerbate ocular
inflammation (Nussenblatt and Whitcup, 2010).
Uveitis may start as early as 5 days or as late as 50 years after injury; however, over 90 % of
cases occur 2 weeks to 1 year (Lubin et al., 1980; Chan et al., 1986; Goto and Rao, 1990;
Bakri and Peters, 2005). In the past, removal of the injured eye was undertaken to protect
against subsequent inflammation of the uninjured eye (Marak, 1979; Winter, 1955).
However, experience prior to the use of prophylactic corticosteroids, and later by our
retrospective study (Chan et al., 1995), demonstrated that enucleation does not prevent the
disease or improve vision (Winter, 1955). Currently, systemic corticosteroids and
immunomodulators are recommended for the treatment of this entity (Castiblanco and
Adelman, 2009).
Blurred vision and photophobia typically herald the involvement of the uninjured eye, while
similar symptoms progress in the injured eye. Granulomatous uveitis ensues with moderate
to severe vitritis and multiple white-yellow lesions in the choroid and deep retina. Under the
microscope, both diffuse and focal infiltrates are seen in the choroid. Dalen-Fuchs nodules
(DFN) represent granulomatous inflammation localized between the RPE and Bruch’s
membrane (Jakobiec et al., 1983; Chan et al., 1985, 1986; Shah et al., 1993). In severe cases,
swelling of the optic nerve head and characteristic “mutton-fat” keratic precipitates on the
posterior surface of the cornea can be observed (Chan et al., 1986). Granulomas are
composed primarily of macrophages (Marak, 1979; Lubin et al., 1980; Chan et al., 1986),
and may also be seen within the retina. These activated macrophages resemble epithelial
cells, and are therefore sometimes referred to as “epithelioid histiocytes”. During the final
stages of the disease, B cells can be found within non-granulomatous infiltrates (Shah et al.,
1993; Abu El-Asrar et al., 2007).
Recently, attention has been directed at understanding the functional properties of the
cytokine milieu in this inflammatory condition. Cytokines are secreted proteins that mediate
and control immune and inflammatory responses. More specifically, cytokines guide the
differentiation of naïve T cells into effector subtypes that constitute the inflammatory
reaction. T helper (Th) lymphocytes are a distinctive subset of T cells that secrete cytokines
that regulate the immune response. Based on their cytokine or interleukin phenotype, Th
cells are subdivided mainly into Th1 (signature cytokines, IL-2 and IFN-γ), Th2 (IL-4, IL-5,
and IL-13), and Th17 (IL-17) subsets, which possess unique functions (Trinchieri, 2007;
Mills, 2008). IL-10 was originally described as a cytokine produced specifically by Th2
cells, but later studies showed that Th1 cells produce at least similar amounts of IL-10 as
Th2 cells (Fitzgerald et al., 2007; Trinchieri, 2007).
IFN-γ is considered the hallmark cytokine of Th1 cells, whereas Th2 cells produce IL-4 and
Th17 cells elaborate IL-17. From a functional perspective, IFN-γ has antiviral,
immunoregulatory, and anti-tumor properties (Schroder et al., 2004). IFN-γ also enhances
antigen presentation to macrophages, activates and increases lysosome activity, and
suppresses Th2 cell activity. Th1 cells produce IL-2, IFN-γ, and tumor necrosis factor
(TNF)-α. In addition, they activate macrophages responsible for cell-mediated immunity,
and are implicated in the pathogenesis of organ-specific autoimmune disorders.
Similar to their T-cell counterparts, macrophage populations are diverse and express
distinctive repertoires of chemokine and chemokine receptors. Macrophages can be induced
to polarize into classically activated M1 macrophages by IFN-γ treatment (Mantovani et al.,
2004). M1 macrophages express high levels of IL-12, IL-23 and low levels of IL-10, and
CCL19 and CXCL11 chemokines.
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CCL19 binds to the chemokine receptor CCR7 and recruits macrophages. In contrast,
CXCL11, a small chemotactic protein for activated T cells, sometimes referred to as the
interferon-inducible T-cell alpha chemoattractant (I-TAC) interferon-gamma-inducible
protein 9 (IP-9), binds to its receptor, CXCR3 (Erdel et al., 1998; O'Donovan et al., 1999).
The gene expression of CXCL11 is strongly induced by IFN-γ and IFN-β and weakly
induced by IFN-α (Rani et al., 1996).
M2 macrophages are involved in the Th2 response and express CCL17 and CCL22 (Benoit
et al., 2008). Unlike defined subtypes of Th lymphocytes, the plasticity of macrophages has
resulted in alteration of their phenotypes over time (Mosser and Edwards, 2008).
IL-23 is a heterodimeric cytokine and an important component of the inflammatory response
against infectious agents that promotes upregulation of matrix metalloprotease 9, increases
angiogenesis, and reduces CD8+ T-cell infiltration. In conjunction with IL-6 and
transforming growth factor-β (TGF-β), it stimulates naïve CD4+ cells to differentiate into
Th17 cells, which are distinct from classical Th1 and Th2 cells. According to previous
investigators, IL-23 is necessary to elicit experimental autoimmune uveoretinitis by
immunization of mice with retinal antigen (Luger et al., 2008). Classic M1 macrophage
activation is elicited by IFN-γ and selected cytokines. In addition, M1 macrophages produce
abundant reactive oxygen and nitrogen intermediates and inflammatory cytokines and are
components of the afferent and efferent limbs of polarized Th1 responses (Mantovani,
2006).
The objective of the present study was to explore the role of inflammatory cells, especially T
cells and macrophages, in the pathogenesis of SO. In addition, we aimed to further
characterize the cytokine milieu of this disease.
Materials and methods
Specimens
This study was conducted in compliance with the Declaration of Helsinki and was approved
by the National Eye Institute Institutional Review Board for human subjects. Archival tissue
specimens from 15 cases of SO from the National Eye Institute/National Institutes of Health
and the Armed Forces Institute of Pathology were collected for this study. The clinical
records were reviewed, and the pathological diagnosis was confirmed by at least two
ophthalmic pathologists.
Microdissection, RNA extraction, and real-time quantitative PCR
Microdissection was performed manually using hematoxylin and eosin (H&E)-stained
samples on glass slides, prepared from formalin-fixed, paraffin-embedded tissue, as
described previously (Zhuang et al., 1995a,b; Zhuang et al., 1995; Shen et al., 1998). The
slides were cut at 6 µm and stored in room temperature.
To obtain reasonably pure populations of inflammatory cells, efforts were made to avoid
sampling regions with overlapping features. Accordingly, inflammatory cells that comprised
the DFN (mainly macrophages), granulomas (mainly macrophages), and non-granulomatous
areas (mainly lymphocytes) were microdissected and collected separately. Subsequently,
macrophage samples collected from the same case were combined and analyzed. Two to
three areas of tissue were microdissected and studied from each case.
Total RNA was isolated using the Paradise Sample Quality Assessment Kit per the
manufacturer’s instructions (Arcturus, Mountain View, CA). The Paradise Sample Quality
Assessment Kit is well known for RNA isolation from the cells on formalin fixed, archived
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slides. Total RNA was reverse-transcribed with Superscript Reverse Transcriptase II
(Invitrogen, Carlsbad, CA). Samples were DNase 1-treated (Fermentas, Glen Burnie, MD),
and cDNAs were synthesized. The resulting cDNA from the SO tissue specimens was used
to measure the relative expression of IFN-γ, IL-17, IL-18, IL-23, CCL17, CCL19, CCL22,
and CXCL11 (SA Biosciences, Frederick, MD). These chemokines/cytokines were selected
because they represent the characteristic molecules produced by Th1, Th2, Th17, M1 and
M2 cells. cDNA amplification was performed using the MX3000P QPCR system (Agilent,
La Jolla, CA) with Green/Rox PCR master mix (SA Biosciences, Frederick, MD) and a
QPCR kit (SA Biosciences, Frederick, MD). SYBR Green fluorescence (PCR product
formation) was monitored in real time. The threshold for detection of PCR products was set
in the log-linear phase of amplification, and the threshold cycle (Ct, number of cycles
required to reach the threshold of detection) was determined for each reaction. Target
mRNA levels were quantified using the manufacturer's instructions and were reported
relative to the level of the housekeeping gene beta-actin by the comparative using ΔΔCT
method. In the event that an individual mRNA level was more than two standard deviations
above those of the group when not included, it was considered an outlier and excluded.
Immunohistochemistry
The avidin-biotin-immunoperoxidase complex (ABC) technique was applied as described
previously (Chan et al., 1985b; Chan and Li, 1998). Briefly, the slides were deparaffinized
and hydrated. Primary antibodies included monoclonal mouse anti-human CD3 (Dako North
America Inc, Carpinteria, California), 1:40 dilution; CD4 (Novocastra, United Kingdom),
1:20 dilution; CD8 (Dako North America Inc, Carpinteria, California), 1:50 dilution; CD20
(Dako North America Inc, Carpinteria, California), 1:40 dilution; CD68 (Dako North
America Inc, Carpinteria, California), 1:100 dilution; and CD163 (Novocastra, United
Longdom), 1:200 dilution antibodies with biotin-conjugated horse anti-mouse IgG as the
secondary antibody.
Statistical analysis
The Mann-Whitney U-test was used to evaluate the statistical differences. SPSS version
17.0 (SPSS Inc., IL) was used for all data analyses. Given the large differences among the
measurements in archival tissue, the median value, which is more appropriate for skewed
data, was calculated. A p value of ≤0.05 was considered statistically significant.
Results
The clinicopathological features of SO are summarized in Table 1. Among the 15 cases, 9
had ocular penetrating injury and 6 were operated previously. The cardinal pathological
feature of uveal granulomatous inflammation (Fig. 1) was observed in all 15 cases. The
inflammatory population outside the granulomas expressed higher IFN-γ mRNA levels (1.0–
34.2) than cells within the granuloma (1.5–7.3), indicating that they were Th1 cells (Fig. 2).
Within granulomas, the relative expression of IL-18 transcripts in granulomas and DFN was
much greater (0–8190.4) than in non-granulomatous infiltrates (T lymphocytes, 0–1746.0)
(Fig. 2), reflecting their origin from bone marrow-derived macrophages. In addition, two M1
macrophage chemokines (CXCL11, CCL19) and two cytokines (IL-18, and IL-23) were
elevated in granulomatous inflammatory cells (1.3–29.8, 2.1–134722.0, 0.0–8190.4, and
1.9–670.8; respectively) (Fig. 3). In particular, IL-23 and CXCL11 showed significantly
greater expression in granulomatous (macrophages, 1.9–670.8 and 1.3–29.8, respectively) as
compared to non-granulomatous (0.0–245.5 and 0.1–3.7, respectively) inflammation
(p<0.05). The relative expression of the CCL17, transcript, a M2 macrophage chemokine,
was greater in non-granulomatous (1.1–95.7) infiltrates. Alternatively, the relative
expression of CCL22, a M0 and M2 chemokine, was significantly greater in granuloma-
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associated T lymphocytes (granuloma 0.9–88.1 vs. non-granuloma 0.0–11.0, p<0.05) (Fig.
4).
CXCL11 and CCL17 were used to analyze the relative distribution of M1 and M2
macrophages. The ratio of CXCL11 to CCL17 was greater than 1.00 in macrophages,
indicating that more M1 than M2 cells were recruited in granulomas and DFN (p<0.05).
Taken together, M1 macrophages comprised a greater proportion of the granulomatous
population, and M2 macrophages were mixed with T lymphocytes in non-granulomatous
areas. The relative expression of IL-17 transcripts in granulomatous inflammatory cells (0.9–
781.9) was much greater than in the non-granulomatous inflammatory cells (T lymphocytes,
0.7–48.7) (Fig. 6).
Discussion
In the present study, our results are the first to provide preliminary evidence that selected
M1 macrophage cytokine and chemokines, IL-23, CCL19, and CXCL11, predominate
within the granulomatous infiltrates of SO. Additionally, we documented relatively high
levels of IL-17 in granulomatous areas and confirmed that IFN-γ-producing Th1 cells are
key components of the non-granulomatous inflammation.
The source of the high levels of IL-17 within granulomas in this condition remains
enigmatic. Interestingly, Gu et al. reported that IL-10-deficient or IL-10R-deficient
macrophages produce high levels of IL-17 and its transcription factor RORγt following LPS
stimulation (Gu et al., 2008). Since macrophages represent the main inflammatory cell
comprising granulomas and DFN, it is possible that macrophages are responsible for the
elaboration of IL-17. In support of this hypothesis, other studies have documented IL-17
production by alveolar macrophages in asthmatic patients (Song et al., 2008), bone marrow-
derived monocytes in Crohn’s disease (Fujino et al., 2003), and in Langerhans cell
histiocytosis (Coury et al., 2008). However, we cannot exclude the possibility that small
numbers of infiltrating Th17 cells may have contributed to the elaboration of IL17 within
granulomas in our samples.
Our results demonstrate that IFN-γ-producing Th1 cells represent the key component of
non-granulomatous inflammation. As reported previously (Chan and Li, 1998; Shen et al.,
1998), T-cells in non-granulomatous areas are mainly CD3-positive (CD4 > CD8) and
express IFN-γ and IL-2 but lack IL-4. In our samples, high levels of IFN-γ mRNA in non-
granulomatous areas documented the presence of active Th1 cells, as observed in an earlier
publication (Chan and Li, 1998). The precise role of IFN-γ in the development of the disease
remains uncertain, with questions persisting as to whether IFN-γ has a protective or
detrimental function with respect to the host eye. One possible explanation is that CXCL11,
a ligand of CXCR3, tends to be expressed on Th1 and CD8 cells, both of which are detected
in SO and both are known to produce IFN-γ. Although we did not quantify CXCL11 levels,
it is likely that CXCL11 production recruits inflammatory cells into the eye that
subsequently damage normal tissue. Future studies will be needed to clarify this hypothesis.
The present study shows that mainly T-lymphocytes and a few macrophages within non-
granulomatous infiltrates not only produce IFN-γ, but also small amounts of CCL17, a M2
chemokine. We also found that CCL17 transcripts were greater in non-granulomatous
infiltrates.
CCL22 expression was low in granulomas, compared to M1 macrophage chemokines
(CCL19 and CXCL11) and IL-23. It has been hypothesized that monocyte-derived dendritic
cells are capable of elaborating CCL22 (Yamashita and Kuroda, 2002). In contrast, cells
from the granulomas and DFN, mainly CD68+, CD163+/− cells, expressed higher levels of
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IL-17, IL-18, IL-23, CCL19, and CXCL11 transcripts. These observations are consistent with
previous reports showing that granulomas and Dalen-Fuchs nodules are composed mainly of
macrophages (CD68+ cells) (Jakobiec et al., 1983; Chan et al., 1986). This investigation
also established that IL-23 and CXCL11 transcripts dominate within granulomas and DFN,
indicating that they are M1 macrophage-rich.
Functional polarization of macrophages into M1 or M2 cells is a useful concept that
describes the plasticity of mononuclear phagocytes. More precisely, the phenotype of a
macrophage population can change over time and may exist in a diverse range of
phenotypes (Mosser and Edwards, 2008). Accordingly, our findings may only reflect a
snapshot of the changing inflammatory milieu of SO in an immune privileged organ, the
eye.
Compared to studies of pulmonary granulomatous diseases, mainly M1 macrophages are
found in Mycobacterium tuberculosis-induced granulomas, whereas M2 macrophages
predominate in Schistosoma mansoni-induced granuloma (Joshi et al., 2008; Redente et al.,
2010). The former is a Th1 initiated disease and the latter is a Th2 initiated disease. Since
SO is considered a Th1 disease, it follows that M1 macrophages are seen in choroidal
granulomas and DFN.
In summary, this is the first investigation to demonstrate that M1 macrophages represent the
predominant cellular element within granulomas and DFN in SO. In addition, we
documented high levels of IL-17 within granulomas and the presence of Th1 and M1 cells.
Although methodological limitations exist with manually isolating specific cell populations,
our findings provide evidence for the participation of dominant inflammatory cell subsets
within the granulomatous and nongranulomatous areas. Further analysis is warranted to
better define the mechanisms of cytokines/chemokines in the pathogenesis of SO, and
whether targeting Th1 lymphocytes, M1 macrophages, and their cytokines/chemokines plus
IL-17, may represent effective therapy.
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Fig. 1.
Histopathology of SO. A large Dalen-Fuchs nodule (DFN) composed predominantly of
macrophages is located between the retina (R) and choroid (C), which is infiltrated by many
lymphocytes. H&E. × 100.
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Fig. 2.
Cytokine gene (IL18 and IFNγ) relative expression in SO. IL18 is highly elevated in the
granuloma, and higher levels of IFNγ are expressed by lymphocytes.
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Fig. 3.
M1 macrophage chemokines (CXCL11, CCL19) and cytokines (IL23) in SO. Chemokines/
cytokines are higher in the granulomatous inflammation (M1 macrophages) as compared to
the non-granulomatous inflammation (T lymphocytes). *: P<0.05
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Fig. 4.
M2 macrophage chemokines (CCL17 and CCL22) in SO. M2 macrophage chemokines are
higher within granulomatous (macrophages) as compared to non-granulomatous
inflammation (T lymphocytes). *: P<0.05.
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Fig. 5.
The ratio of M1 (CXCL11) to M2 (CCL17) macrophage chemokines in SO. The ratio of
CXCL11 to CCL17 was greater than 1.00 in macrophages, indicating that more M1 than M2
cells were found in granulomas and Dalen-Fuchs nodules. *: P<0.05.
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Fig. 6.
Cytokine gene relative expression (IL17) in SO. IL17 expression is higher within
granulomatous as compared to non-granulomatous inflammation.
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Table 1
The clinical features of SO in 15 cases.
Case# Age Sex Type of Injury or Surgery
1 46 F Multiple intraocular surgery, catract extraction, vitrectomy with repare RD 2times
2 38 M Ruptured globe
3 6 M Penetrating corneal injury
4 NA F RD
5 NA M Perforated corneoscleral injury
6 82 F Vitrectomy for endophthalmitis following catract extraction
7 30 F Trauma
8 72 NA Pars planau vitrectomy and scleral buckling procedure for RD, extracapsular catract extraction
9 59 F Intracapsular catract extraction and blunt trauma
10 32 F Ruptured globe, perforating limbal cornea
11 11 F Lacerated corneal injury with prolapsed iris
12 24 F Perforating limbal corneal injury
13 34 M Perforating limbal injury
14 44 F Pals plana Vitrectomy RD, DM
15 36 F Corneal perforation
Footnote: NA, not applicable due to missing data.
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